Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,095,179
+$1,219,269 QoQ
Shares Held
4,248
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.23%
of 13F equity value
Holder Rank
#1,697
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banco de Sabadell, S.A holds $14,969,128 across 7 Drug Manufacturers - General names. LLY ranks #1 (34.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,248 | $5,095,179 | |
| 2 | JNJ |
Johnson & Johnson
|
12,879 | $3,270,879 | |
| 3 | AMGN |
Amgen Inc
|
6,877 | $2,490,299 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,969 | $1,538,016 | |
| 5 | NVO |
Novo Nordisk A S
|
18,330 | $878,740 | |
| 6 | SNY |
Sanofi
|
20,466 | $873,079 | |
| 7 | NVS |
Novartis AG
|
5,251 | $822,936 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,095,179 | 4,248 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $3,875,910 | 4,214 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,884,421 | 4,545 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,542,609 | 4,643 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,648,200 | 4,680 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,982,538 | 4,822 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,499,476 | 4,533 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,889,276 | 4,390 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,104,087 | 4,533 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,594,953 | 4,621 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,861,553 | 4,909 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,676,518 | 4,983 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,516,077 | 5,365 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,304,004 | 6,709 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,289,426 | 6,258 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,461,016 | 7,611 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,437,236 | 7,517 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,532,942 | 8,845 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,331,020 | 8,439 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,673,033 | 7,241 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,674,348 | 7,295 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,301,672 | 39,084 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,768,170 | 22,318 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,748,606 | 25,325 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $6,064,316 | 36,937 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $1,072,028 | 7,728 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||